Green Synthesis of Gold Nanoparticles using Arabidopsis thaliana and Dunaliella salina Cell Cultures

Chumakov, D. S.; Sokolov, A. O.; Богатырев, В. А.; Sokolov, O. I.; Selivanov, N. Yu.; Дыкман, Л. А.

doi:10.1134/s1995078018050038

Cited by 7 publications

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…By the bioreduction method, the metal ions are chemically reduced by bacterial enzymes, and the synthesized NPs can be easily removed from the reaction. The bioinspired strategies imply the production of NPs by living organisms such as plants [81,82], bacteria [83], and fungi [84], as well as the use of biological extracts and enzymes as a primary source of precursors [85,86].…”

Section: Metal Particlesmentioning

confidence: 99%

Nanoparticle-Based Approaches towards the Treatment of Atherosclerosis

et al. 2020

View full text Add to dashboard Cite

Atherosclerosis, being an inflammation-associated disease, represents a considerable healthcare problem. Its origin remains poorly understood, and at the same time, it is associated with extensive morbidity and mortality worldwide due to myocardial infarctions and strokes. Unfortunately, drugs are unable to effectively prevent plaque formation. Systemic administration of pharmaceuticals for the inhibition of plaque destabilization bears the risk of adverse effects. At present, nanoscience and, in particular, nanomedicine has made significant progress in both imaging and treatment of atherosclerosis. In this review, we focus on recent advances in this area, discussing subjects such as nanocarriers-based drug targeting principles, approaches towards the treatment of atherosclerosis, utilization of theranostic agents, and future prospects of nanoformulated therapeutics against atherosclerosis and inflammatory diseases. The focus is placed on articles published since 2015 with additional attention to research completed in 2019–2020.

show abstract